Phytochemistry of Red Ginseng, a Steam-Processed Panax ginseng

CZ Wang, CF Zhang, QH Zhang… - The American Journal of …, 2024 - World Scientific
Asian ginseng, the root of Panax ginseng CA Meyer, occupies a prominent position in the list
of best-selling natural products in the world. There are two major types of ginseng roots …

The development and application of pseudoviruses: assessment of SARS-CoV-2 pseudoviruses

C Tan, N Wang, S Deng, X Wu, C Yue, X Jia, Y Lyu - PeerJ, 2023 - peerj.com
Although most Coronavirus disease (COVID-19) patients can recover fully, the disease
remains a significant cause of morbidity and mortality. In addition to the consequences of …

[HTML][HTML] New perspective on the immunomodulatory activity of ginsenosides: focus on effective therapies for post-COVID-19

Y Wang, Q Han, S Zhang, X Xing, X Sun - Biomedicine & Pharmacotherapy, 2023 - Elsevier
More than 700 million confirmed cases of Coronavirus Disease-2019 (COVID-19) have
been reported globally, and 10–60% of patients are expected to exhibit “post-COVID-19 …

Korean red ginseng relieves inflammation and modulates immune response induced by pseudo-type SARS-CoV-2

KW Kwon, JW Kim, S Moon, JH Yoon… - The American Journal …, 2023 - World Scientific
Few studies have reported the therapeutic effects of Korean red ginseng (KRG) against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the positive …

3-Fucosyllactose-Mediated Modulation of Immune Response against Virus Infection

S Moon, KW Lee, M Park, J Moon, SH Park… - International Journal of …, 2024 - Elsevier
3-Fucosyllactose-Mediated Modulation of Immune Response against Virus Infection -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Help …

[HTML][HTML] Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2

HJ Kim, Y Oh, S Moon, J Oh, JH Kim, SH Lee… - Journal of Ginseng …, 2024 - Elsevier
Background Developing antiviral agents against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been a global goal since the Coronavirus Disease 2019 …

Conversion of Host Cell Receptor into Virus Destructor by Immunodisc to Neutralize Diverse SARS‐CoV‐2 Variants

J Hwang, BK Kim, S Moon, W Park… - Advanced …, 2024 - Wiley Online Library
The decreasing efficacy of antiviral drugs due to viral mutations highlights the challenge of
developing a single agent targeting multiple strains. Using host cell viral receptors as …

Exploring immune evasion of SARS-CoV-2 variants using a pseudotyped system

H Duan, E Zhang, G Ren, Y Cheng, B Yang, L Liu… - Heliyon, 2024 - cell.com
Abstract In the United States, coronavirus disease 2019 (COVID-19) cases have consistently
been linked to the prevailing variant XBB. 1.5 of SARS-CoV-2 since late 2022. A system has …

COVID-19 pandemic and the immune regulatory function of foods

GD Kim, SY Lee, HS Shin - Food Science and Industry, 2022 - koreascience.kr
Coronavirus, known as one of the causes of colds including mild upper respiratory tract
disease in humans, has mutated into the infectious severe disease, COVID-19 through …